Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CapsoVision (CV) EBT (2024 - 2025)

CapsoVision (CV) has disclosed EBT for 2 consecutive years, with -$7.4 million as the latest value for Q4 2025.

  • Quarterly EBT fell 59.25% to -$7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$25.3 million for FY2025, 27.17% down from the prior year.
  • EBT hit -$7.4 million in Q4 2025 for CapsoVision, up from -$7.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$4.6 million in Q2 2025 to a low of -$7.9 million in Q3 2025.